Vascular System Injury clinical trials at UC Irvine
1 research study open to eligible people
Showing trials for
Humacyte Human Acellular Vessel (HAV) in Patients With Vascular Trauma
open to eligible people ages 18-85
This study evaluates the use of the Human Acellular Vessel (HAV) in adults with vascular trauma below the neck who are undergoing vascular reconstructive surgery. There will be a torso cohort and a limb cohort. All subjects will be implanted with a HAV as an interposition vessel or bypass using standard vascular surgical techniques. There is no control arm.
Orange, California and other locations